Aciphex and Renagel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aciphex (rabeprazole sodium) and Renagel (sevelamer hydrochloride). Common drug interactions include pain in extremity among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Aciphex and Renagel. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.
What is Aciphex?
Aciphex has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 25,301 Aciphex users. Check the latest studies of Aciphex.
What is Renagel?
Renagel has active ingredients of sevelamer hydrochloride. eHealthMe is studying from 8,246 Renagel users. Check the latest studies of Renagel.
39 people who take Aciphex and Renagel together, and have interactions are studied.

What are the common drug interactions of Aciphex and Renagel, by gender? *:
female:
- Pain in extremity
- Rash papular (redness with papule)
- Renal failure (kidney dysfunction)
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Skin hypertrophy (skin cells enlarges)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin plaque (red, scaly patches to appear on the skin)
- Skin tightness
- Nausea (feeling of having an urge to vomit)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
male:
- Death
- Renal failure (kidney dysfunction)
- Family stress
- Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Hypoaesthesia (reduced sense of touch or sensation)
- Malaise (a feeling of general discomfort or uneasiness)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Rash erythematous (redness of the skin)
- Rash papular (redness with papule)
What are the common drug interactions of Aciphex and Renagel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Back pain
- Emotional distress
- Exfoliative rash (scaly red generalized skin rash)
- Gait disturbance
- Hyperkeratosis (thickening of the outer layer of the skin)
- Joint range of motion decreased (disease of joint movement)
- Muscle fatigue (a condition in which muscles cannot exert their normal force)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
40-49:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
50-59:
- Arthropathy
- Chronic kidney disease
- Deformity (disfigurement)
- Dry skin
- Gait disturbance
- Hypoaesthesia (reduced sense of touch or sensation)
- Induration (thickening of tissue)
- Joint stiffness
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Mitral valve disease (disease of mitral valve of heart)
60+:
- Nausea (feeling of having an urge to vomit)
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Malaise (a feeling of general discomfort or uneasiness)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Blood pressure systolic increased
- Circulatory collapse
What are the existing conditions these people have? *
- High Blood Pressure: 16 people, 41.03%
- Pain: 10 people, 25.64%
- Anaemia (lack of blood): 7 people, 17.95%
- High Blood Cholesterol: 6 people, 15.38%
- Renal Disorder (kidney disease): 5 people, 12.82%
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 5 people, 12.82%
- Type 2 Diabetes: 4 people, 10.26%
- Bloody Peritoneal Effluent: 4 people, 10.26%
- Diabetes: 4 people, 10.26%
- Diarrhea: 4 people, 10.26%
* Approximation only. Some reports may have incomplete information.
Do you take Aciphex and Renagel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aciphex and Renagel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aciphex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Renagel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aciphex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Renagel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and sevelamer hydrochloride (the active ingredients of Aciphex and Renagel, respectively), and Aciphex and Renagel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metoprolol Tartrate cause Bundle Branch Block Left? - 2 seconds ago
- Could Lantus cause Pulmonary Function Test Decreased? - 6 seconds ago
- Could Tizanidine Hydrochloride cause Cough? - 7 seconds ago
- Drug interactions of Ginkgo Biloba and Simvastatin - 10 seconds ago
- Could Benadryl cause Strabismus? - 15 seconds ago
- Drug interactions of Ninlaro and Lexapro - 21 seconds ago
- Drug interactions of Toradol and Levothyroxine Sodium - 29 seconds ago
- Could Calcium Carbonate cause Hyperthyroidism? - 33 seconds ago
- Drug interactions of Potassium Phosphate and Clopidogrel - 39 seconds ago
- Could Xalatan cause Injection Site Reaction? - 49 seconds ago